Here's the live share price of Ajanta Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Ajanta Pharma has gained 20.00% CAGR. Over the past year, the corresponding return has been -18.86%.
Ajanta Pharma’s current P/E of 34.33x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Ajanta Pharma | -1.46 | -4.97 | 0.37 | -0.75 | -18.86 | 26.28 | 20.00 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Ajanta Pharma has declined 18.86% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Ajanta Pharma has outperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 2,571.82 | 2,563.02 |
10 | 2,569.58 | 2,567.89 |
20 | 2,585.32 | 2,583.62 |
50 | 2,651.7 | 2,613.51 |
100 | 2,621.9 | 2,632.08 |
200 | 2,678.76 | 2,645.4 |
In the latest quarter, Ajanta Pharma remained same as its previous close in promoter holding, while DII stake increased to 17.50%, FII holding unchanged at 8.86%, and public shareholding unchanged at 7.38% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Nippon India Small Cap Fund | 16,74,471 | 0.64 | 414.87 |
UTI Flexi Cap Fund | 13,05,600 | 1.27 | 323.48 |
Kotak Small Cap Fund - Regular Plan | 12,19,302 | 1.73 | 302.09 |
Nippon India Pharma Fund | 9,59,323 | 2.84 | 237.68 |
Canara Robeco Emerging Equities | 9,28,520 | 0.9 | 230.05 |
HDFC Large and Mid Cap Fund - Regular Plan | 8,97,224 | 0.85 | 222.3 |
UTI Mid Cap Fund | 8,24,875 | 1.75 | 204.37 |
Nippon India Multi Cap Fund | 6,07,460 | 0.33 | 150.5 |
Canara Robeco Small Cap Fund | 5,79,013 | 1.14 | 143.46 |
PGIM India Midcap Opportunities Fund | 4,24,692 | 0.92 | 105.22 |
Date Time | Announcement |
---|---|
Sep 02, 2025, 2:36 PM IST | Ajanta Pharma Lt - Participation In Investor Conference |
Jul 31, 2025, 4:36 PM IST | Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Jul 28, 2025, 10:54 PM IST | Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Jul 28, 2025, 9:05 PM IST | Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Jul 28, 2025, 8:35 PM IST | Ajanta Pharma Lt - Board Meeting Outcome for Outcome Of The Board Meeting |
Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 4322.04 Cr. and Equity Capital is Rs. 25.07 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ajanta Pharma is ₹2,556.00 as on Sep 17, 2025.
The Ajanta Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Ajanta Pharma is ₹31,927.53 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Ajanta Pharma are ₹2,565.00 and ₹2,535.10.
The 52-week high/low is the highest and lowest price at which Ajanta Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Ajanta Pharma is ₹3,464.00 and 52-week low of Ajanta Pharma is ₹2,022.05 as on Sep 17, 2025.
The Ajanta Pharma has shown returns of 0.14% over the past day, -4.97% for the past month, 0.37% over 3 months, -18.86% over 1 year, 26.28% across 3 years, and 20.0% over 5 years.
P/E ratio of and PB ratio of Ajanta Pharma are 34.33 and 8.68 on Sep 17, 2025. While the company gives a dividend yield of 1.10 per annum.